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Abstract
Background: Abdominal aortic aneurysm (AAA) is a frequent cause of death among elderly. Patients affected by
lower extremity peripheral arterial disease (LE-PAD) seem to be particularly at high risk for AAA. We aimed this
study at assessing the prevalence and the clinical predictors of the presence of AAA in a homogeneous cohort of
LE-PAD patients affected by intermittent claudication.
Methods: We performed an abdominal ultrasound in 213 consecutive patients with documented LE-PAD (ankle/
brachial index ≤0.90) attending our outpatient clinic for intermittent claudication. For each patient we registered
cardiovascular risk factors and comorbidities, and measured neutrophil count.
Results: The ultrasound was inconclusive in 3 patients (1.4%), thus 210 patients (169 males, 41 females, mean age
65.9 ± 9.8 yr) entered the study. Overall, AAA was present in 19 patients (9.0%), with a not significant higher
prevalence in men than in women (10.1% vs 4.9%, p = 0.300). Patients with AAA were older (71.2 ± 7.0 vs 65.4 ±
9.9 years, p = 0.015), were more likely to have hypertension (94.7% vs 71.2%, p = 0.027), and greater neutrophil
count (5.5 [4.5 – 6.2] vs 4.1 [3.2 – 5.5] x103/μL, p = 0.010). Importantly, the c-statistic for neutrophil count (0.73, 95%
CI 0.60 – 0.86, p =0.010) was higher than that for age (0.67, CI 0.56–0.78, p = 0.017). The prevalence of AAA in
claudicant patients with a neutrophil count ≥ 5.1 x103/μL (cut-off identified at ROC analysis) was as high as 29.0%.
Conclusions: Prevalence of AAA in claudicant patients is much higher than that reported in the general
population. Ultrasound screening should be considered in these patients, especially in those with an elevated
neutrophil count.
Introduction
Systemic atherosclerosis represents the leading cause of
morbidity and mortality in the western countries [1-3],
with increased prevalence in the elderly population [4,5].
The atherosclerotic disease may involved different part
of vascular tree, in particular coronary arteries, carotid
arteries and peripheral arteries [6,7] .
Abdominal aortic aneurysm (AAA) is a frequent cause
of death in the elderly and its incidence has increased
during last decades because of the increasing life-expec-
tancy and the development of easy and low-cost diagnos-
tic tools like ultrasound [5,8-12]. The rising incidence of
AAA and the severe prognosis in case of rupture with a
mortality rate that can be as high as 90% [13] call for
early identification and elective repair. However, oppos-
ing views have been published on the importance of
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the high-risk populations who need to be screened
[14,15].
Lower extremity peripheral arterial disease (LE-PAD),
one of the main expressions of atherosclerosis, affects
about 27 million people in Europe and the United States
[16] and is associated with a high risk of developing fatal
and non-fatal ischemic cardiovascular events [2,17-19].
Patients affected by LE-PAD seem to be at particularly
high risk for AAA development [20-22]. Accordingly, we
aimed this study at assessing the prevalence and the clini-
cal predictors of the presence of AAA in a homogeneous
cohort of LE-PAD patients affected by intermittent claudi-
cation, the most frequent clinical expression of LE-PAD.
Methods
We performed an abdominal ultrasound in 213 consecu-
tive patients with documented LE-PAD attending our out-
patient complaining intermittent claudication. Using an
Image Point Hx ultrasound system (Hewlett Packard) and
a 3.0 MHz transducer, we measured in each patient both
antero-posterior and transverse outer diameters at the
largest portion of the infrarenal abdominal aorta. AAA was
defined by an infrarenal abdominal aorta diameter ≥ 3 cm
[23]. Infrarenal abdominal aortas 2.6 to 2.9 cm were
defined ectatic.
The diagnosis of PAD was based on the presence of an
ankle brachial index (ABI) ≤ 0.90. ABI was measured after
participants had rested supine for 5 minutes. The systolic
blood pressure in both brachial arteries, and the ankle sys-
tolic blood pressure in the right and left posterior tibial
and dorsalis pedis arteries were measured using a Doppler
probe. The ABI for each leg was then determined using
the higher of the two readings from either the posterior
tibial or dorsalis pedis arteries, and the higher of the two
brachial readings. The lower ABI of the two legs was used
for diagnostic purposes.
In each patient, clinical history and risk factors were
assessed. Smokers included current and former smokers.
Hypertension was diagnosed if systolic arterial pressure
exceeded 140 mmHg and/or diastolic arterial pressure
exceeded 90 mmHg, or if the patient used antihypertensive
drugs. Hypercholesterolemia was diagnosed if plasma total
cholesterol exceeded 200 mg/dL, plasma low-density lipo-
protein cholesterol exceeded 130 mg/dL, or if the patient
used lipid-lowering drugs because of a history of hyperch-
olesterolemia. Diabetes mellitus was diagnosed if plasma
fasting glucose exceeded 126 mg/dL or if the patient used
hypoglycaemic agents. A history of coronary artery disease,
previous myocardial infarction, or ischemic stroke was
documented by hospital records. All patients underwent
ultrasound examination of carotid arteries.
All participants gave written informed consent to the
study, which was approved by our institutional Ethics
Committee.
Blood samples and laboratory assay
Blood was drawn from an antecubital vein using a 19-
gauge needle in a Vacutainer system (Becton-Dickson,
Franklin Lakes, NJ). Neutrophil count was measured with
the Bayer H*2 hematology analyzer (Bayer Diagnostic
Division, Tarrytown, NY).
Statistical analysis
Statistical analyses were performed using SPSS 12.0
(SPSS, Inc., Chicago, IL, USA). Variables were expressed
as absolute numbers and percentage or mean ± SD, with
the exception of neutrophil count, which was expressed
as median and inter-quartile range because of their
skewed distribution. Comparisons were made by t-test
for unpaired samples, c2 test, or Mann–Whitney U test,
as appropriate. For continuous variables, receiver-operat-
ing characteristic (ROC) curve analysis was used to iden-
tify the threshold levels that provided the best cut-off for
the prediction of the presence AAA. Correlations
between continuous variables were evaluated by Spear-
man analysis.
All statistical tests were two-sided. For all tests, a
p-value <0.05 was considered statistically significant.
Results
The ultrasound was inconclusive in 3 patients (1.4%),
thus 210 patients (169 males, 41 females, mean age
65.9 ± 9.8 yr) completed the study. Table 1 shows base-
line characteristics of the study population. Overall,
AAA was present in 19 patients (9.0%), with a not sig-
nificant higher prevalence in men than in women
(10.1% vs 4.9%, p = 0.300). Furthermore, patients with
AAA were older (71.2 ± 7.0 vs 65.4 ± 9.9 years, p = 0.015),
were more likely to have hypertension (94.7% vs 71.2%,
p = 0.027), and greater neutrophil count (5.5 [4.5 – 6.2] vs
4.1 [3.2 – 5.5] x103/μL, p = 0.010) (Table 2). The preva-
lence progressively increased with age (p for trend =
0.013), with a maximum of 15.8% in over 75-year-subjects
(Table 3). Of note, in our population we observed a higher
prevalence of carotid stenosis >50% in claudicant patients
with AAA, although not significant (47.4 vs 29.3%, p =
0.105). No relationship was found between the ankle/bra-
chial index and the presence of AAA. For continuous vari-
ables, which are associated to the presence of AAA at
univariate analysis (i.e. age and neutrophil count), ROC
curve analysis was performed to evaluate the best cut-offs
to predict the presence of the disease (Figure 1). The best
cut-offs were ≥ 66 years for age and ≥ 5.1 × 103/μL for
neutrophil count. Importantly, the c-statistic for neutro-
phil count (0.73, 95% CI 0.60 – 0.86, p = 0.010) was higher
than that for age (0.67, CI 0.56–0.78, p = 0.017) (Figure 1).
In our population the prevalence of AAA in claudicant
patients with a neutrophil count ≥ 5.1 × 103/μL (cut-off
identified at ROC analysis) was as high as 29.0%. Of note,
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Spearman analysis showed that neutrophil count and age
are not correlated (r = -0.123, p = 0.230).
Discussion
The present study demonstrates that prevalence of AAA
in claudicant patients is much higher than that reported
in the general population, with the highest clinical pre-
dictors being advanced age and an elevated inflamma-
tory status.
To decrease the number of deaths from ruptured AAA,
early detection by screening subjects at high risk is needed.
Physical examination is not effective in identifying the pre-
sence of an AAA, while abdominal ultrasound is an accu-
rate test to detect the presence of this life-threatening
disease [23]. Elderly males are those who show the highest
prevalence of the disease in the general population. Indeed
there is evidence that screening programs involving males
with > 65 years are cost-effective [14,24,25]. The strong
association with age has been confirmed also in our popu-
lation of claudicant patients. Indeed, we observed that the
prevalence of AAA dramatically increases after 65 years
(optimal cut-off identified at ROC analysis being ≥ 66
years) and no AAA was found in patients younger than 55
years of age. Thus age cut-off to initiate screening for
AAA in patients with intermittent claudication seems to
be the same than in general population. These results
might suggest that performing an abdominal ultrasound in
all claudicant patients may not be advisable. However, in
our study, we found that an elevated inflammatory status,
evaluated by neutrophil count, is a powerful predictor of
the presence of AAA in patients with intermittent claudi-
cation, and that the neutrophil count did not correlate
with age. Initiating the screening in patients ≥ 65 years
with intermittent claudication might consequently lead to
Table 1 Baseline characteristics of the study population (n=210)
Number Percentage or mean (SD) or median [25th-75th percentiles]
Age (years) 65.9 (9.8)
Males 169 80.5
Height (cm) 167.4 (7.5)





Diabetes mellitus 75 35.7
BMI (kg/m2) 26.2 (3.4)
WC (cm) 97.6 (9.4)
Metabolic syndrome 96 45.7
Comorbidity
CAD 106 50.5
Previous MI 76 36.2
Previous stroke 8 3.8
Medications
Antiplatelets 191 91.0




Carotid stenosis >50% 65 31
LE-PAD severity
Bilateral LE-PAD 131 62.4
ABI 0.69 (0.22)
Aortic features
Aortic diameter (mm) 20.7 (6.8)
Ectatic aorta 13 6.2
AAA 19 9.0
Inflammatory status
Neutrophil count (x103/μL) 4.4 [3.3-5.7]
SD = standard deviation; BMI = body mass index; WC = waist circumference; CAD = coronary artery disease; MI = myocardial infarction; ACE = angiotensin
converting enzyme; LE-PAD = lower extremity-peripheral arterial disease; ABI = ankle/brachial index; AAA = abdominal aortic aneurysm.
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miss some diagnosis of AAA, and therefore in claudicant
patients with an elevated inflammatory status the ultra-
sound screening should be performed irrespective of age.
At this regard, pathophysiological studies are needed to
evaluate whether the increased inflammation observed in
our population of intermittent claudication patients
affected by AAA is a cause or a consequence of the pre-
sence of AAA [19,26,27].
Conclusions
The high prevalence of AAA among patients affected by
intermittent claudication makes them a suitable target
population for AAA screening. In our opinion ultra-
sound screening should be considered in these patients,
especially in those with an elevated neutrophil count.
However, further studies are warranted to elucidate if
screening all patients with intermittent claudication for
of this life-threatening condition is cost-effective.
List of abbreviations
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Table 2 Characteristics of claudicants according to the
presence or absence of AAA.
AAA No AAA p
(n = 19) (n = 191)
Age (years) 71.2 ± 7.0 65.4 ± 9.9 0.015
Age ≥ 65 years 16 (84.2) 110 (57.6) 0.024
Males 17 (89.5) 152 (79.6) 0.300
Risk factors
Smoking 18 (94.7) 170 (89.0) 0.437
Hypertension 18 (94.7) 136 (71.2) 0.027
Hypercholesterolemia 15 (78.9) 122 (63.9) 0.188
Diabetes Mellitus 4 (21.1) 71 (37.2) 0.162
BMI (kg/m2) 26.5 ± 3.7 26.2 ± 3.4 0.742
WC (cm) 96.7 ± 9.6 97.7 ± 9.4 0.708
Metabolic syndrome 9 (47.4) 87 (45.5) 0.879
Comorbidity
CAD 10 (52.6) 96 (50.3) 0.844
Previous MI 5 (26.3) 71 (37.2) 0.348
Previous stroke 1 (5.2) 7 (3.7) 0.729
Medications
Antiplatelets 18 (94.7) 173 (90.6) 0.547
Beta blockers 2 (10.5) 45 (23.6) 0.194
ACE-inhibitors 11 (57.9) 93 (48.7) 0.444
Statins 10 (52.6) 120 (62.8) 0.383
Carotid status
Carotid stenosis >50% 9 (47.4) 56 (29.3) 0.105
LE-PAD severity
Bilateral LE-PAD 13 (68.4) 118 (61.8) 0.569
ABI 0.64 ± 0.11 0.69 ± 0.23 0.315
Inflammatory status
Neutrophil count (x103/μL) 5.5 [4.5 – 6.2] 4.1 [3.2 – 5.5] 0.010
Values are n (%) or mean ± SD or median [interquartile range].
AAA = abdominal aortic aneurysm; BMI = body mass index; WC = waist
circumference; CAD = coronary artery disease; MI = myocardial infarction; ACE
= angiotensin converting enzyme; LE-PAD = lower extremity-peripheral
arterial disease; ABI = ankle/brachial index; SD = standard deviation.
Table 3 Distribution of AAA by age.
Total AAA Prevalence
Age < 55 years 25 0 0%
Age 55 – 64 years 59 3 5.1%
Age 65 – 74 years 88 10 11.4%
Age ≥ 75 years 38 6 15.8%
p for trend = 0.013
Figure 1
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